Studies Aim to Find Long COVID Treatments
VOA Learning English
31 October 2022
Researchers are studying treatments for the long-lasting effects of COVID infections, known as long COVID. They are excited to learn if naltrexone can offer similar helpful effects to millions of people suffering from health problems months after a coronavirus infection.
Naltrexone is one of a few treatments to be tested in the U.S. National Institutes of Health's $1 billion RECOVER Initiative. Unlike treatments aimed at symptoms caused by COVID damage to organs, such as the lungs, low-dose naltrexone (LDN) may reverse some of the problems that are creating symptoms, they said.
Several studies on LDN and Long COVID are being conducted.